FIGO (1988) | FIGO (2013) |
---|---|
I: Tumor limited to the ovaries | I: Tumor confined to ovaries or fallopian tube(s)a |
IA: Tumor limited to 1 ovary (capsule intact), no tumor on ovarian surface, no malignant cells in ascites or peritoneal washings | IA: Tumor limited to 1 ovary (capsule intact) or fallopian tube; no tumor on ovarian or fallopian tube surface; no malignant cells in the ascites or peritoneal washings |
IB: Tumor limited to both ovaries (capsules intact), no tumor on ovarian surface, no malignant cells in ascites or peritoneal washings | IB: Tumor limited to both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in the ascites or peritoneal washings |
IC: Tumor limited to 1 or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings | IC: Tumor limited to 1 or both ovaries or fallopian tube(s) with any of the following: |
IC1: Surgical spill intraoperatively | |
IC2: Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface | |
IC3: Malignant cells in the ascites or peritoneal washings | |
II: Tumor involves 1 or both ovaries with pelvic extension | II: Tumor involves 1 or both ovaries or fallopian tubes with pelvic extension (below pelvic brim) or primary peritoneal cancerb |
IIA: Extension and/or implants on uterus and/or tube(s); no malignant cells in ascites or peritoneal washings | IIA: Extension and/or implants on uterus and/or fallopian tubes and/or ovaries |
IIB: Extension to other pelvic tissues; no malignant cells in ascites or peritoneal washings | IIB: Extension to other pelvic intra-peritoneal tissues |
IIC: Pelvic extension (IIA or IIB) with malignant cells in ascites or peritoneal washings | Â |
III: Tumor involves 1 or both ovaries with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastasis | III: Tumor involves 1 or both ovaries or fallopian tubes, or primary peritoneal cancer, with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes |
IIIA: Microscopic peritoneal metastasis beyond pelvis | IIIA1: Positive retroperitoneal lymph nodes only (cytologically or histologically proven) |
IIIA1(i): Metastasis up to 10Â mm in greatest dimension | |
IIIA1(ii): Metastasis more than 10Â mm in greatest dimension | |
IIIA2: Microscopic extra-pelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes | |
IIIB: Macroscopic peritoneal metastasis beyond pelvis, 2Â cm or less in greatest dimension | IIIB: Macroscopic peritoneal metastasis beyond the pelvis up to 2Â cm in greatest dimension, with or without metastasis to the retro-peritoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ) |
IIIC: Peritoneal metastasis beyond pelvis more than 2Â cm in greatest dimension and/or regional lymph node metastasis | IIIC: Macroscopic peritoneal metastasis beyond the pelvis more than 2Â cm in greatest dimension, with or without metastasis to the retro-peritoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ) |
IV: Distant metastasis (excludes peritoneal metastasis) | IV: Distant metastasis excluding peritoneal metastases |
IVA: Pleural effusion with positive cytology | |
IVB: Parenchymal metastases and metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity)c |